Azitra (AZTR) Retained Earnings (2022 - 2026)
Azitra (AZTR) posted Retained Earnings of $82.9 million for Q1 2026, up 221.02% on a QoQ basis from -$68.5 million in Q4 2025, and up 236.84% year-over-year from $24.6 million in Q1 2025.
Azitra (AZTR) Retained Earnings (2022 - 2026) Analysis & Trends
Azitra's Retained Earnings history runs 5 years deep, the most recent figure standing at $82.9 million for Q1 2026.
- Quarterly Retained Earnings rose 236.84% year-over-year to $82.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.9 million (up 236.84% YoY) and the FY2025 annual result came in at -$68.5 million, down 208.31% from the prior year.
- Retained Earnings was $82.9 million for Q1 2026 at Azitra, up from -$68.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $82.9 million in Q1 2026 and bottomed at -$68.5 million in Q4 2025.
- A 5-year average of -$13.0 million and a median of -$46.1 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings slumped 4710.13% — and 2026, when it soared 236.84%.
- Azitra's Retained Earnings stood at $1.1 million in 2022, then slumped by 4710.13% to -$48.6 million in 2023, then surged by 230.18% to $63.3 million in 2024, then slumped by 208.31% to -$68.5 million in 2025, then soared by 221.02% to $82.9 million in 2026.
- Business Quant data shows AZTR's Retained Earnings at $82.9 million in Q1 2026, -$68.5 million in Q4 2025, and $68.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - | -27.27 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | -279.01 Mn |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn | 12.91 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn | 14.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn | 11.90 Mn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | -24.89 Mn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - | -622,000.00 |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - | 82.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.93 Mn |
| Dec 31, 2025 | -68.52 Mn |
| Sep 30, 2025 | 68.57 Mn |
| Jun 30, 2025 | -63.50 Mn |
| Mar 31, 2025 | -60.60 Mn |
| Dec 31, 2024 | 63.26 Mn |
| Sep 30, 2024 | -55.17 Mn |
| Jun 30, 2024 | -54.16 Mn |
| Mar 31, 2024 | 55.85 Mn |
| Dec 31, 2023 | -48.60 Mn |
| Sep 30, 2023 | -46.14 Mn |
| Jun 30, 2023 | -44.20 Mn |
| Dec 31, 2022 | 1.05 Mn |